Celyad Oncology SA American Depositary Shares
CYAD
CYAD was delisted on the 18th of May, 2023.
10 hedge funds and large institutions have $25.4M invested in Celyad Oncology SA American Depositary Shares in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
23% less funds holding
Funds holding: 13 → 10 (-3)
32% less capital invested
Capital invested by funds: $37.6M → $25.4M (-$12.1M)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
+$3.41M |
| 2 |
HM
HealthCor Management
New York
|
+$1.14M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$1.02M |
| 4 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
+$528K |
| 5 |
Morgan Stanley
New York
|
+$147K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$5.27M |
| 2 |
Millennium Management
New York
|
-$4.26M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.56M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$780K |
| 5 |
FMA
FNY Managed Accounts
New York
|
-$286K |
CYAD Hedge Fund Activity: Q3 2015 in Review
10 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Celyad Oncology SA American Depositary Shares (CYAD) for Q3 2015, worth a combined $25.4M — down 32% from $37.6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CYAD and 2 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was RS Investment Management, adding an estimated $3.41M. The largest seller was UBS Group, cutting an estimated $5.27M.
- 10 institutional investors held Celyad Oncology SA American Depositary Shares (CYAD) as of Q3 2015, down from 13 in Q2 2015.
- Funds reported $25.4M of Celyad Oncology SA American Depositary Shares stock for Q3 2015, down 32% quarter-over-quarter.
- 2 funds opened new Celyad Oncology SA American Depositary Shares positions in Q3 2015 and 5 closed out, a net change of -3 holders.
- The largest Celyad Oncology SA American Depositary Shares buyer in Q3 2015 was RS Investment Management, an estimated $3.41M added.
- The largest Celyad Oncology SA American Depositary Shares seller in Q3 2015 was UBS Group, an estimated $5.27M sold.
Based on aggregated 13F filings for Q3 2015.